Amgen, Inc. (AMGN) Stock Price Today
Key Stats
- $195.01BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $388.16FIFTY_TWO_WEEK_HIGH
- $271.18FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $240.30BENTERPRISE_VALUE
- 2.79%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $388.16, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Most Recent News
Law firm investigates fiduciary breaches at First Solar, Hub Group, Navan, and ZoomInfo for misleading shareholders.
Grabar Law Office is investigating claims against officers and directors of First Solar, Hub Group, Navan, and ZoomInfo for alleged breaches of fiduciary duties and securities fraud. The investigations focus on misleading statements and omissions rel...
Trump Accounts launch July 4 with default investment in low-cost S&P 500 ETF SPYM.
The U.S. Treasury Department announced that Trump Accounts will officially launch on July 4, with all contributions initially invested in the low-cost State Street SPDR Portfolio S&P 500 ETF (SPYM). This ETF was chosen for its broad exposure to the U...
ProShares UltraPro S&P 500 (UPRO) suited for active traders amid volatile market, hold recommended.
ProShares UltraPro S&P 500 (UPRO) offers triple daily leverage on the S&P 500, making it ideal for active traders who want to capitalize on short-term market swings. The analyst expects a flat to slightly positive outlook for the S&P 500 in 2026, lim...